سعر كلير اير 10 مجم 14 قرص 2024

Clear Air 10 mg film-coated tablets (Amoun): montelukast (leukotriene receptor antagonist) for asthma/allergic rhinitis related use per class labelling.

• Prophylaxis and chronic treatment of asthma in adults and adolescents 15 years and older (10 mg film-coated tablet).DailyMed / Organon LLC
• Prevention of exercise-induced bronchoconstriction in patients 15 years and older.DailyMed / Organon LLC
• Relief of symptoms of allergic rhinitis (seasonal in 2+ years; perennial in 6 months+ per US label age bands — Egyptian 10 mg tablet typically for adolescents/adults).DailyMed / Organon LLC

• Upper respiratory infection, fever, headache, pharyngitis, cough, abdominal pain, diarrhoea, otitis, influenza, rhinorrhoea, sinusitis; neuropsychiatric events as in Warnings.International label, same formulation · DailyMed / Organon LLC

• Hypersensitivity to montelukast or any component of the formulation.International label, same formulation · DailyMed / Organon LLC

• Neuropsychiatric events (agitation, aggression, depression, sleep disturbances, suicidal thinking/behaviour) have been reported; advise patients/caregivers and discontinue if they occur.International label, same formulation · DailyMed / Organon LLC
• Not for acute asthma attacks; do not use as monotherapy for exercise-induced bronchospasm needing rescue therapy without an appropriate reliever.International label, same formulation · DailyMed / Organon LLC
• Eosinophilic conditions / Churg-Strauss-like vasculitis reported rarely, often with systemic corticosteroid reduction.International label, same formulation · DailyMed / Organon LLC

• Phenobarbital / rifampin (CYP inducers)ModerateStrong CYP inducers may reduce montelukast plasma levels; clinical significance usually limited but monitor.DailyMed / Organon LLC
• GemfibrozilModerateGemfibrozil may increase montelukast exposure (CYP2C8 inhibition); no routine dose adjustment stated for 10 mg in US label but be aware.DailyMed / Organon LLC

• Available data from published studies have not established a drug-associated risk of major birth defects, miscarriage, or adverse maternal/fetal outcomes; animal data do not indicate teratogenicity at clinically relevant exposures.International label, same formulation · DailyMed / Organon LLC
• Montelukast is present in human milk; consider developmental/health benefits of breastfeeding along with maternal need and any potential adverse effects.International label, same formulation · DailyMed / Organon LLC

• Montelukast: Orally active, selective antagonist of the cysteinyl leukotriene type-1 (CysLT1) receptor, blocking LTD4-mediated airway oedema, smooth-muscle contraction and inflammation (SINGULAIR US label).